ASIMPKIP D-R Elena Docheva EOOD
- Address
- Zornitsa 58 Bl Fl1 Room 14, 8000 Burgas, Bulgaria
ASIMPKIP D-R Elena Docheva EOOD - Cardiovascular Research Center
ASIMPKIP D-R Elena Docheva EOOD is a specialized clinical research facility dedicated to advancing cardiovascular medicine through participation in cutting-edge international trials. The center demonstrates particular expertise in heart failure therapeutics and preventive cardiology, focusing on novel interventions for patients with diverse cardiovascular conditions ranging from acute heart failure to chronic atherosclerotic disease.
- Heart failure with reduced ejection fraction (HFrEF) and preserved ejection fraction (HFpEF) therapeutic trials
- Atherosclerotic cardiovascular disease (ASCVD) prevention and lipid management studies
- Advanced lipid disorders including elevated lipoprotein(a) intervention research
- Cardiovascular-metabolic disease management in obesity-related heart conditions
The research center's portfolio reflects expertise across the full spectrum of heart failure phenotypes, from reduced to preserved ejection fraction, as well as primary and secondary cardiovascular prevention strategies. With particular attention to novel lipid-lowering therapies including RNA-based interventions and dual-action medications addressing both metabolic and cardiovascular endpoints, the facility plays a vital role in evaluating next-generation treatments for complex cardiovascular-metabolic syndrome patients.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Amgen Inc.1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Amgen Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in ASIMPKIP D-R Elena Docheva EOOD
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Finerenone in Reducing Morbidity and Mortality in Heart Failure Patients with LVEF ≥40% Hospitalized for Acute Decompensated Heart Failure | Colorado Prevention Center | Phase III | Recruiting | Oct 2024 | — |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Atorvastatin | 1 | Unknown | 2021-11-26 | 2021-11-26 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.